Literature DB >> 20839384

Prostate cancer. The promise of psychostimulants for disease-related fatigue.

Suzanne J Farley.   

Abstract

Entities:  

Year:  2010        PMID： 20839384     DOI： 10.1038/nrurol.2010.136

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

Authors:  Amanda R Moraska; Amit Sood; Shaker R Dakhil; Jeff A Sloan; Debra Barton; Pamela J Atherton; Jason J Suh; Patricia C Griffin; David B Johnson; Aneela Ali; Peter T Silberstein; Steven F Duane; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

2.  Methylphenidate for fatigue in ambulatory men with prostate cancer.

Authors:  Andrew J Roth; Christian Nelson; Barry Rosenfeld; Howard Scher; Susan Slovin; Michael Morris; Noelle O'Shea; Gabrielle Arauz; William Breitbart
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.